Unknown

Dataset Information

Poor Prognosis of COVID-19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross-Sectional Population Study Of 252 119 Patients.


ABSTRACT:

Objective

Coronavirus disease 2019 (COVID-19) has progressed rapidly around the world, reaching a lethality of up to 20% due to acute respiratory distress syndrome (ARDS). This latter condition is a relevant concern for systemic lupus erythematosus (SLE); however, data on this topic are limited to few case series. Our objective was to evaluate in hospitalized patients with SLE and with COVID-19-associated ARDS (confirmed by reverse transcription-polymerase chain reaction) the risk of mortality and combined poor outcomes (death, intensive care unit [ICU] admission, and/or mechanical ventilation [MV] use) and to compare with that of patients without SLE.

Methods

This is a nationwide cross-sectional study of patients with severe acute respiratory syndrome coronavirus 2 nested i

SUBMITTER: Bertoglio IM 

PROVIDER: S-EPMC8593786 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature